Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 18, 2023

SELL
$15.0 - $22.17 $2,010 - $2,970
-134 Reduced 1.14%
11,580 $174,000
Q2 2023

Jul 28, 2023

SELL
$21.6 - $30.69 $67,478 - $95,875
-3,124 Reduced 21.05%
11,714 $253,000
Q1 2023

Apr 12, 2023

SELL
$23.07 - $32.77 $1,222 - $1,736
-53 Reduced 0.36%
14,838 $417,000
Q4 2022

Jan 24, 2023

SELL
$25.29 - $35.48 $6,651 - $9,331
-263 Reduced 1.74%
14,891 $0
Q3 2022

Oct 18, 2022

SELL
$24.0 - $33.42 $192 - $267
-8 Reduced 0.05%
15,154 $436,000
Q2 2022

Jul 12, 2022

BUY
$24.78 - $33.36 $375,714 - $505,804
15,162 New
15,162 $384,000

Others Institutions Holding EMBC

About Embecta Corp.


  • Ticker EMBC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 57,836,500
  • Market Cap $1.17B
  • Description
  • Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...
More about EMBC
Track This Portfolio

Track Koshinski Asset Management, Inc. Portfolio

Follow Koshinski Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Koshinski Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Koshinski Asset Management, Inc. with notifications on news.